Overview

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
Phase:
Phase 3
Details
Lead Sponsor:
MEDRx USA, Inc.
Collaborator:
MEDRx Co., Ltd.
Treatments:
Etodolac
Lidocaine